Incretin-based therapies: A focus on safety concerns and emerging uses

News
Article

Incretin-based therapies are now the most promising therapies for type 2 diabetes.

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
Medication Prior Authorization Biggest Daily Challenge for 1 in 5 Prescribers, Survey Says

Medication Prior Authorization Biggest Daily Challenge for 1 in 5 Prescribers, Survey Says

Logan Lutton
August 14th 2025
Article

Read More

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

Briana Contreras
August 14th 2025
Podcast

Listen

FDA Approves Ajovy for Childhood Migraine Prevention

FDA Approves Ajovy for Childhood Migraine Prevention

Logan Lutton
August 14th 2025
Article

Read More

ZAKARIYAE-stock@adobe.com

FDA Grants Accelerated Approval For Targeted Drug for Rare Brain Tumor

Denise Myshko
August 14th 2025
Article

Read More

kitsawet-stock@adobe.com

Valneva Updates Safety Label of Chikungunya Virus Vaccine

Denise Myshko
August 14th 2025
Article

Read More

FDA Approves Presbyopia Treatment, VIZZ

FDA Approves Presbyopia Treatment, VIZZ

Logan Lutton
August 14th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.